ESG Report shows status quo and outlines path for future sustainability improvements

Shareholders approved all motions at today’s AGM 2023

Stifel initiates research coverage of Xlife Sciences

Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million

Xlife Sciences with significant progress in H1 2023

Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector